We collected information about Tiburio Therapeutics Inc Hours for you. Follow the liks to find out everything about Tiburio Therapeutics Inc Hours.
https://www.cydanco.com/cydan-newcos/newco/tiburio-therapeutics-inc/
Cydan NewCos Tiburio Therapeutics, Inc. Tiburio advances novel treatments for rare neuroendocrine tumors and rare endocrine diseases. Tiburio is Cydan’s third orphan drug company, launched in January of 2019 with $31M in financing. Tiburio is a clinical stage biopharmaceutical company dedicated to advancing novel treatments for rare ...
https://www.crunchbase.com/organization/tiburio-therapeutics
Founded Date 2018. Founders Chris Adams, Imran Babar, James McArthur, Michael Culler. Operating Status Active. Last Funding Type Series A. Legal Name Tiburio Therapeutics. Company Type For Profit. Contact Email [email protected]. Phone Number +1 (617) 231-6050. Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.The company's compounds aid …
https://craft.co/tiburio-therapeutics
Tiburio Therapeutics has 7 employees at their 1 location and $31 m in total funding,. See insights on Tiburio Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.
https://www.bloomberg.com/profile/company/1689368D:US
Company profile page for Tiburio Therapeutics Inc including stock price, company news, press releases, executives, board members, and contact information
https://pitchbook.com/profiles/company/264431-71
Tiburio Therapeutics General Information Description. Provider of novel treatments designed to treat rare neuroendocrine tumors and rare endocrine diseases. The company's clinical stage compounds aids to treat non-functioning pituitary adenoma using a dopamine-somatostatin chimeric molecule that has the potential to shrink or halt tumor growth, enabling patients to get effective …
https://www.ventureradar.com/organisation/Tiburio%20Therapeutics/9daa2f5a-ac3c-406a-a75b-b08b15502fe2
Listed. Spero Therapeutics, Inc. is a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for multi-drug-resistant (MDR) bacterial infections and rare diseases. Spero’s lead product candidate, tebipenem HBr (tebipenem pivoxil hydrobromide; formerly SPR994), is being ...
https://www.bizapedia.com/de/tiburio-therapeutics-inc.html
Tiburio Therapeutics Inc. is a Delaware Corporation filed On October 23, 2018. The company's File Number is listed as 7115189. The Registered Agent on file for this company is The Corporation Trust Company and is located at Corporation Trust Center 1209 Orange St, Wilmington, DE 19801.
Searching for Tiburio Therapeutics Inc Hours?
You can just click the links above. The info is collected for you.
